Join us for another virtual meeting of the New York-Russia Public Policy Seminar. This panel is co-hosted by Columbia University’s Harriman Institute and the New York University Jordan Center for the Advanced Study of Russia.
Vladimir Putin’s announcement in August 2020 that Russia had become the first country to grant regulatory approval to a COVID-19 vaccine—Sputnik V—generated much fanfare domestically but was initially met with skepticism among expert global scientific communities. Now, with more published results from trials, we see wider acceptance of the claims of the vaccine’s efficacy and a surging global demand for the vaccine from around the world. Please join this distinguished panel of researchers and commentators as we explore how the vaccine was developed in Russia, the issues surrounding its scientific review, and how the Kremlin is now incorporating “vaccine diplomacy” into its broader foreign policy strategy.
Enrico Bucci, Adjunct Professor of Biology; Director of the System Biology program of the Sbarro Health Research Organization, Temple University
Judyth Twigg, Professor of Political Science at Virginia Commonwealth University
Joshua Yaffa, correspondent for The New Yorker based in Moscow
Alexandra Yatsyk, University of Tartu
Alexander Cooley, Director of the Harriman Institute, Columbia University
Joshua Tucker, Director of the Jordan Center for the Advanced Study of Russia, New York University